Use Cases & News

See our products and services in action. Get the latest news from the industry and our company.

Latest publications
Machine learning filtering of antibody NGS: NaturalAntibody Batch Sequence Annotation module

Machine learning filtering of antibody NGS: NaturalAntibody Batch Sequence Annotation module

The NaturalAntibody platform now includes a feature called Batch Sequence Annotation. Users can upload a batch of sequences and filter it by specific attributes to quickly find the most promising candidates and accelerate their work.

Read more
batch sequence annotation
How AI reduces the cost and time of drug discovery and development

How AI reduces the cost and time of drug discovery and development

There is no question that drug discovery has become increasingly competitive and expensive, driving pharmaceutical companies to look into new methods for reducing R&D costs. Artificial Intelligence promises to solve key industry challenges and significantly speed up the discovery process to help companies reclaim a sizeable chunk of their costs.

Read more
AI, drug discovery
Biotech and pharma companies need AI to keep innovating during the recession

Biotech and pharma companies need AI to keep innovating during the recession

What can leaders do today to keep that focus and persevere through the economic downturn? I believe the answer lies in AI and its potential for redefining business processes and models.

Read more
AI in drug discovery
Get to know literature datasets in our antibody search platform

Get to know literature datasets in our antibody search platform

Our Antibody Database ecosystem draws from multiple sources, among other scientific publications that make up the Literature Database. This is a database of manually-curated antibody sequences from scientific publications. It contains information that helps antibody engineering teams quickly identify sequences and scientific publications they were retrieved from.

Read more
antibody database
How to check antibody data against a target in the NaturalAntibody platform

How to check antibody data against a target in the NaturalAntibody platform

One of the most valuable use cases of the NaturalAntibody Antibody Database is advanced search empowered by synonymization, which allows users to check all the key data about antibodies developed against a specific target.

Read more
use case
NaturalAntibody releases a new intuitive tool for accessing high-throughput antibody data and AI analytics

NaturalAntibody releases a new intuitive tool for accessing high-throughput antibody data and AI analytics

The bioinformatics company NaturalAntibody released AbStudio - a web-based solution that helps scientists discover antibody-based drug candidates to speed up research decision-making.

Read more
AbStudio
Machine-designed biotherapeutics: opportunities, feasibility, and advantages of Deep Learning in antibody discovery

Machine-designed biotherapeutics: opportunities, feasibility, and advantages of Deep Learning in antibody discovery

Our review provides a critical overview of the recent developments in deep learning approaches to therapeutic antibody design, with implications for fully computational antibody design.

Read more
publication
NaturalAntibody partners with Icosagen Cell Factory to accelerate antibody discovery

NaturalAntibody partners with Icosagen Cell Factory to accelerate antibody discovery

NaturalAntibody, the leading bioinformatics company accelerating antibody discovery with AI-based products for the pharma industry, has launched a partnership with Icosagen Cell Factory (CRDMO) - experts in discovering and producing antibodies with pharma companies.

Read more
company news
DeepMind AlphaFold for antibody discovery: What's the status?

DeepMind AlphaFold for antibody discovery: What's the status?

Can AlphaFold2 help in the antibody discovery process? Our team at NaturalAntibody carried out some tests to check its potential. Read this article to find out what we discovered.

Read more
AlphaFold2
Business benefits of AI-driven antibody drug discovery

Business benefits of AI-driven antibody drug discovery

Antibodies represent the fastest-growing class of biotherapeutics on the market because of their naturally favorable attributes. How can pharmaceutical companies harness the potential of antibodies with the help of computational solutions based on AI?

Read more
antibody engineering
NaturalAntibody appoints Dr. Sonia Wróbel as Senior Product Manager

NaturalAntibody appoints Dr. Sonia Wróbel as Senior Product Manager

​​We have great news to share - Dr. Sonia Wróbel joined NaturalAntibody as Senior Product Manager! Dr. Wróbel has over 6 years of experience in the biotechnology industry across a range of business roles. As a holder of both doctoral and MBA degrees, Dr. Wróbel has experience in bringing complex scientific products to market. She is going to support our team in realizing our mission of accelerating antibody-based drug discovery to deliver life-saving therapeutics faster.

Read more
company news
What's it like to work in a biotech startup? Interview with NaturalAntibody VP of Engineering

What's it like to work in a biotech startup? Interview with NaturalAntibody VP of Engineering

What's it like to work in an R&D-led biotechnology startup? What challenges do software development teams solve, and what skills can they acquire? Read this interview with Piotr, our VP of Engineering, to get the scoop on a developer's work in this unique setting.

Read more
software engineering, Big Data
AbDiver – A tool for exploring the natural antibody landscape to support therapeutic design

AbDiver – A tool for exploring the natural antibody landscape to support therapeutic design

AbDiver is an online tool that helps researchers make the most of the vast NGS data on antibody mutations by allowing them to spot parallels between natural and therapeutic antibodies. AbDiver accelerates the decision-making process during the lead optimization stage for a more efficient therapeutic pipeline.

Read more
abdiver
Introduction to antibody numbering

Introduction to antibody numbering

An essential prerequisite for antibody analysis is the use of standardized numbering methods. What exactly is antibody numbering and how does it work?

Read more
antibody numbering, antibody analysis
NaturalAntibody appoints Piotr Deszyński as VP of Engineering

NaturalAntibody appoints Piotr Deszyński as VP of Engineering

NaturalAntibody, a bioinformatics company developing computational methods for antibody-based drug discovery, has appointed Piotr Deszyński as VP of Engineering, a tech leader with over 15 years of experience in the industry across CTO and tech lead roles.

Read more
company news
Introduction to antibody functional structure

Introduction to antibody functional structure

Where do antibodies come from? What is the structure of an antibody? And how does it all work? Keep on reading to learn the essentials of antibody function and how it comes about as a result of its sequence and structure.

Read more
antibody structure
NaturalAntibody awarded $1.7 million non-equity research grant to expand its AI platform for developing therapeutic antibodies

NaturalAntibody awarded $1.7 million non-equity research grant to expand its AI platform for developing therapeutic antibodies

NaturalAntibody, the leading bioinformatics company accelerating antibody discovery with AI-based solutions for the pharma industry, was awarded a $1.7 million grant from the National Centre for Research and Development for industrial Research & Development projects.

Read more
company news, press release
​​What is antibody engineering and how is it transforming drug discovery today?

​​What is antibody engineering and how is it transforming drug discovery today?

Get a (brief) introduction to antibody therapeutics, different techniques for antibody engineering, and context on how computational approaches are now steadily transforming this rapidly expanding field.

Read more
antibody engineering
INDI - an integrated nanobody database for immunoinformatics

INDI - an integrated nanobody database for immunoinformatics

To design nanobody-based drugs, scientists need databases that collate the increasing volume of biological sequence data in the public domain. To address this problem, we developed Integrated Nanobody Database for Immunoinformatics (INDI) - a novel nanobody database that collates nanobody information from all the major data repositories in the public domain.

Read more
nanobodies, database, INDI
AbDiver – a tool for exploring the natural sequence diversity of antibodies for therapeutic design

AbDiver – a tool for exploring the natural sequence diversity of antibodies for therapeutic design

AbDiver is an online platform that helps scientists to navigate the vast NGS data sets on antibody mutations. Allowing to draw parallels between natural and therapeutic antibodies, the solution supports and accelerates the decision-making process in the rational design of therapeutics at the lead optimization stage for a faster therapeutic pipeline.

Read more
abdiver; antibody sequence
NaturalAntibody management board awarded in 50 Most Creative People in Business Ranking

NaturalAntibody management board awarded in 50 Most Creative People in Business Ranking

We’re excited to share that the Management Board of NaturalAntibody was awarded a top 10 position in the 11th edition of the 50 Most Creative People in Business Ranking.

Read more
company news
Antibody-specific patent search engine for faster design of antibody therapeutics

Antibody-specific patent search engine for faster design of antibody therapeutics

By accessing antibody data in patent documents via NaturalAntibody infrastructure, researchers can accelerate the antibody development process. They can quickly check whether the sequence they’re working on has already been developed by another company and use data stored in patents to study similar antibodies with their targets and engineering properties.

Read more
patent search, patent database, use case, antibody data
NaturalAntibody appoints ex-AstraZeneca CFO Jakob Saga as Chief Commercial Officer

NaturalAntibody appoints ex-AstraZeneca CFO Jakob Saga as Chief Commercial Officer

​​We have fantastic news to share today - Jakob Saga joined NaturalAntibody as Chief Commercial Officer! Mr. Saga has over 12 years of experience in the pharmaceutical industry, working as a Finance Manager and CFO in globally renowned companies. His business acumen and expert knowledge are going to support our team in realizing our mission of accelerating antibody-based drug discovery to deliver life-saving therapeutics faster.

Read more
new hire, company news